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Summary
Objective: To identify an appropriate cell source for the generation of meniscus substitutes, among those which would be available by arthros-
copy of injured knee joints.
Methods: Human inner meniscus cells, fat pad cells (FPC), synovial membrane cells (SMC) and articular chondrocytes (AC) were expanded
with or without speciﬁc growth factors (Transforming growth factor-beta1, Fibroblast growth factor-2 and Platelet-derived growth factor bb,
TFP) and then induced to form three-dimensional cartilaginous tissues in pellet cultures, or using a hyaluronan-based scaffold (Hyaff-11),
in culture or in nude mice. Human native menisci were assessed as reference.
Results: Cell expansion with TFP enhanced glycosaminoglycan (GAG) deposition by all cell types (up to 4.1-fold) and messenger RNA
expression of collagen type II by FPC and SMC (up to 472-fold) following pellet culture. In all models, tissues generated by AC contained
the highest fractions of GAG (up to 1.9% of wet weight) and were positively stained for collagen type II (speciﬁc of the inner avascular region
of meniscus), type IV (mainly present in the outer vascularized region of meniscus) and types I, III and VI (common to both meniscus regions).
Instead, inner meniscus, FPC and SMC developed tissues containing negligible GAG and no detectable collagen type II protein. Tissues
generated by AC remained biochemically and phenotypically stable upon ectopic implantation.
Conclusions: Under our experimental conditions, only AC generated tissues containing relevant amounts of GAG and with cell phenotypes
compatible with those of the inner and outer meniscus regions. Instead, the other investigated cell sources formed tissues resembling only
the outer region of meniscus. It remains to be determined whether grafts based on AC will have the ability to reach the complex structural
and functional organization typical of meniscus tissue.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Meniscus is a complex ﬁbrocartilaginous tissue, which is
essential in the knee joint for shock absorption, load distri-
bution, maintenance of stability and protection of articular
cartilage1e3. Injuries to the meniscus are often treated by
partial or total meniscectomy, which is known to be associ-
ated with detrimental changes in joint function, ultimately
increasing the risk of early degenerative joint diseases4e6.
Surgical approaches currently in use to substitute the
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Received 21 October 2005; revision accepted 17 June 2006.48damaged meniscus (e.g., the use of allografts or of a colla-
gen-based material) can initially restore a stable and pain-
free joint, but long-term clinical results, especially related
to the protection of the articular surface, are still
uncertain7,8. Recently, tissue engineering strategies have
been proposed for the generation of meniscus substitutes,
based on the loading and culture of suitable cells into
appropriate biodegradable porous scaffolds9e12. The prom-
ising approach has been pre-clinically validated by several
studies11,13, indicating the potential of cell-based meniscus
substitutes to improve healing of meniscus tissue.
Several cell sources have been used for meniscus repair,
including meniscus ﬁbrochondrocytes11,12,14,15, chondro-
cytes13,16,17 or bone marrow-derived mesenchymal
progenitor cells18e20, but to the best of our knowledge a direct
comparison of the different cell types has not yet been estab-
lished. With the ultimate goal to identify an appropriate cell
source for the generation of meniscus substitutes, the aim
of our work was to compare the growth and post-expansion
chondrogenic capacity of different cell types that would be
49Osteoarthritis and Cartilage Vol. 15, No. 1readily available duringmeniscectomy or arthroscopic exam-
ination of an injured knee joint. In particular, we investigated
the following human cell types: (1) innermeniscus cells (IMC)
(hereafter referred to as ‘‘meniscus cells’’), which constitute
the native target tissue and can be expanded even following
meniscus injury15; (2) fat pad cells (FPC), known to include
multipotent mesenchymal progenitor cells21; (3) synovial
membrane cells (SMC), reported to have a progenitor na-
ture22,23 and to be involved in healing of cartilage lesions24,25;
and (4) articular chondrocytes (AC), currently in clinical use
for articular cartilage repair and capable of differentiation
into a variety of mesenchymal tissues26e28. All cells were ex-
panded with or without growth factors previously reported to
enhance chondrogenesis of different chondrocyte types29,30,
and then induced to form three-dimensional (3D) cartilagi-
nous tissues in a scaffold-free model system (i.e., pellet cul-
ture), or using a hyaluronan-based scaffold, following in vitro
culture or in vivo ectopic implantation. Each model included
a culture phase in the presence of chondrogenic supple-
ments, typically used to induce the expression of glycosami-
noglycan (GAG) and collagens31,32. Tissues were assessed
for the content ofGAG, and the expression pattern of different
collagen types was compared to that in the different regions
of native human menisci.
Materials and methods
HUMAN MATERIAL
Meniscus, fat pad and synovial membrane tissues were
obtained from a total of 15 donors (26e68 years of age,
mean 45), after informed consent. Biopsies were harvested
during partial meniscectomy or anterior cruciate ligament
reconstruction, no longer than 2 months after trauma. At
the time of surgery, knee joints were not overtly inﬂamed
or osteoarthritic, although a few cases displayed minor
inﬂammation (4/15 donors), International Cartilage Repair
Society score (ICRS) Grade 1 cartilage damage (2/15 do-
nors), or moderate osteoarthrosis (3/15 donors). Meniscus
(n¼ 15), fat pad (n¼ 7) and synovial membrane (n¼ 12) bi-
opsies were all relatively small in size, with a weight range
of, respectively, 10e500 mg, 10e100 mg, and 20e400 mg.
Meniscus biopsies were only from the inner avascular re-
gion, where injured tissue is typically resected. Synovial
membrane was from the suprapatellar recess and adipose
tissue from the infrapatellar fat pad. For ethical reasons, ar-
ticular cartilage could not be harvested from the same do-
nors. Cartilage tissues were thus collected from the medial
femoral condyle of six cadavers (22e55 years of age,
mean 42), with no known clinical history of joint disorders,
within 24 h after death. Based on a preliminary study, the
growth and differentiation ability of chondrocytes isolated
from macroscopically normal cartilage shortly after knee
joint trauma was within the range of chondrocytes isolated
from cadaver joints. The weight range for the articular carti-
lage specimens was 500e1000 mg.
Complete humanmeniscus specimenswere also obtained
with ethical permission and consent from32 individualsmade
anonymous (18e86 years of age, mean 56), undergoing
above kneeamputation or partialmeniscectomy for traumatic
or degenerative tears. Complete meniscus specimens were
processed for immunohistochemical analysis as described
below and used to deﬁne the pattern of collagen types
expressed in the deep inner avascular and deep outer vascu-
larized regions of the nativemeniscus tissue. Analysis did not
include characterization of the superﬁcial layer of the
meniscus.CELL ISOLATION AND CULTURE
Inner meniscus and articular cartilage biopsies were ﬁnely
minced and digested by incubation for 22 h at 37C in
0.15% type II collagenase (Worthington Biochemical
Corporation, Lakewood, NJ) (1 mL solution per 100 mg
tissue)33. Meniscus cells and AC were resuspended in
Dulbecco’s Modiﬁed Eagle’s Medium (DMEM; 4.5 g/L
glucose with nonessential amino acids), containing 10%
fetal bovine serum, 4.5 mg/mL glucose, 0.1 mM nonessential
amino acids, 1 mM sodium pyruvate, 100 mM 4-(2-hydrox-
yethyl)-1-piperazineethanesulfonic acid (HEPES) buffer,
100 U/mL penicillin, 100 mg/mL streptomycin and 0.29 mg/
mL L-glutamine (control medium).
Fat pad and synovial membrane biopsies were grossly
cut and digested by incubation, respectively, for 7 h and
for 22 h in 0.4% type II collagenase (1 mL solution per
40 mg tissue). For the isolation of FPC, ﬂoating adipocytes
were removed by centrifugation at 300 g for 5 min34. Colla-
genase concentration and incubation times were selected
by adapting a previously published protocol22, following
preliminary tests.
Meniscus, FPC, SMC and AC were plated in tissue cul-
ture ﬂasks, at a density of 104 cells/cm2, and cultured in
a humidiﬁed incubator at 37C and 5% CO2. Throughout
the phase of expansion in monolayer, all cell sources
were cultured in control medium, without or with further
supplementation of 1 ng/mL Transforming growth factor-
beta1 (TGF-b1), 5 ng/mL Fibroblast growth factor-2 and
10 ng/mL Platelet-derived growth factor-bb (TFP medium).
The growth factors (all from R&D Systems, Minneapolis,
MN) were selected based on their previously reported ca-
pacity to enhance the growth and post-expansion chondro-
genic ability of different human chondrocyte types29,30.
DIFFERENTIATION ASSAYS
Upon reaching subconﬂuence, meniscus, FPC, SMC and
AC were detached using 0.05% trypsin/0.53 mM ethylene-
diaminetetraacetic (EDTA) (GIBCO-BRL, CH) and replated
at a density of 5 103 cells/cm2. Following an additional
passage of expansion, cells were used in the three different
models described below.
Model I: chondrogenic differentiation in 3D
pellet culture
Meniscus, FPC, SMC and AC from all donors, expanded
with or without TFP, were suspended in a deﬁned serum
free medium, consisting of DMEM supplemented with
InsulineTransferrineSelenium (ITSþ1) (10 mg/mL insulin,
5.5 mg/mL transferrin, 5 ng/mL selenium, 0.5 mg/mL bovine
serum albumin, 4.7 ng/mL linoleic acid, from Sigma Chemi-
cal, St Louis, MO), 1 mM sodium pyruvate, 100 mM HEPES
buffer, 100 U/mL penicillin, 100 mg/mL streptomycin,
0.29 mg/mL L-glutamine, 0.1 mM ascorbic acid 2-phosphate,
1.25 mg/mL human serum albumin, 10 ng/mL TGF-b1 and
107 Mdexamethasone.The serum freemediumwas initially
developed for the chondrocytic differentiation of humanmes-
enchymal progenitor cells35 and is typically used for the redif-
ferentiation of humanAC29. Aliquots of 5 105 cells in 0.5 mL
of serum free medium were centrifuged in 1.5 mL conical
polypropylene tubes (Sarstedt, Nu¨mbrecht, D) at 1300 rpm
for 4 min to form spherical pellets. These were placed on
a 3D orbital shaker (Bioblock Scientiﬁc, Frenkendorf, CH)
at 30 rpm in a humidiﬁed incubator at 37C and 5% CO2.
Pellets were cultured for 2 weeks, with medium changes
twice per week, and subsequently processed for histological,
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(mRNA) analysis as described below. Each analysis was
performed independently in at least two entire pellets for
each primary culture and expansion condition.
Model II: chondrogenic differentiation in 3D
scaffold based cultures
Meniscus, FPC, SMC and AC from two donors,
expanded with TFP, were seeded into non-woven meshes
(5 mm diameter, 2 mm thick disks), made of esteriﬁed hya-
luronan (Hyaff-11, Fab, Abano Terme, IT) at the density
4 106 cells/scaffold (7 107 cells/cm3). The scaffold was
selected based on previous reports indicating that it sup-
ports redifferentiation of human AC36 and since it is already
in clinical use for articular cartilage repair37. Cells were re-
suspended in 28 mL of control medium and slowly dispersed
over the top surface of the dry meshes with a micropipette.
The seeded scaffolds were transferred to a 37C incubator
to allow for initial cell attachment. After 45 min, 100 mL of
medium was carefully added to the base of each well. After
a further 1.5 h of incubation, 2 mL of medium was slowly
added along the side of each well to cover the scaffold.
Cell-scaffold constructs were cultured in control medium
supplemented with 1 ng/mL of TGFb-3, 0.1 mM ascorbic
acid 2-phosphate and 10 mg/mL of human insulin, with
medium changes twice a week. After 2, 4 and 6 weeks,
the resulting tissues were processed for histological,
immunohistochemical, biochemical or mRNA analysis as
described below. Each analysis was performed indepen-
dently in at least three engineered tissues for each primary
culture and cell source.
Model III: ectopic implantation in nude mice
Meniscus, FPC, SMC and AC from one donor, expanded
with TFP, were loaded and cultured for 2 weeks into
Hyaff-11 meshes as described for Model II and implanted
subcutaneously in nude mice (CD-1 nude/nude, Charles
River, Germany). After 6 weeks, mice were euthanised
and explants processed for histological, immunohistochem-
ical, biochemical or mRNA analysis as described below.
Each analysis was performed independently in two engi-
neered tissues for each cell source.
ANALYTICAL METHODS
Proliferation rate during expansion
The number of doublings of each cell type during the sec-
ond passage of expansion was determined as the logarithm
in base 2 of the fold increase in the number of cells during
expansion. The proliferation rate was deﬁned as the num-
ber of doublings during the second passage of expansion
divided by the time required for expansion and was ex-
pressed as doublings/day.
Real time Reverse Transcription-Polymerase Chain
Reaction (RT-PCR) (global amplification)
Total RNA was prepared from pellet cultures using Tri-
Reagent (Sigma, UK). Pellet cultures were ground up in
the Tri-Reagent using Molecular Grinding Resin (Geno
Technology Inc, St Louis, USA). Complementary DNA
(cDNA) was synthesised from 10 to 100 ng of total RNA
by global ampliﬁcation38. Globally ampliﬁed cDNA was
diluted 1:1000 and 1 ml aliquots of the diluted cDNA wereampliﬁed by real time RT-PCR in a 25 mL reaction volume
on a MJ Research Opticon using a SYBR Green Core Kit
(Eurogentec, Seraing, Belgium), with gene speciﬁc primers
designed using ABI Primer Express software. Relative
expression levels were normalised using glyceraldehyde
3-phosphate dehydrogenase (GAPDH) and calculated
using the 2DCt method39. All primers were from Invitrogen,
Paisley, UK. Primer sequences were for (1) GAPDH: for-
ward 50e30 CACTCAGACCCCCACCACAC, and reverse
50e30 GATACATGACAAGGTGCGGCT; (2) collagen type
I: forward 50e30 TTGCCCAAAGTTGTCCTCTTCT, and
reverse 50e30 AGCTTCTGTGGAACCATGGAA; (3) colla-
gen type II: forward 50e30 CTGCAAAATAAAATCTCGGTG
TTCT, and reverse 50e30 GGGCATTTGACTCACACCAGT;
(4) SOX9: forward 50e30 CTTTGGTTTGTGTTCGTGTTTT
G, and reverse 50e30 AGAGAAAGAAAAAGGGAAAGG
TAAGTTT. The expression levels of collagen types I, II
and SOX-9 were investigated to determine the relative
extent of cell differentiation towards a ﬁbrocartilaginous or
hyaline-like phenotype.
Biochemistry
Tissues generated by meniscus, FPC, SMC and AC were
digested with protease K (1 mg/mL protease K in 50 mM
Tris with 1 mM EDTA, 1 mM iodoacetamide, and 10 mg/
mL pepstatin-A; 0.5 mL solution for cell pellets and 1 mL
for Hyaff-11 based constructs) for 15 h at 56C34. The
GAG content was measured spectrophotometrically using
dimethylmethylene blue40, with chondroitin sulfate as a stan-
dard, and normalized to the DNA amount, measured using
the CyQUANT cell proliferation assay kit (Molecular Probes,
Eugene, OR), with calf thymus DNA as a standard.
Histology
Tissues were rinsed in Phosphate Buffer Solution (PBS),
ﬁxed in 4% buffered formalin for 24 h at 4C, embedded in
parafﬁn, and sectioned to a thickness of 5 mm for cell pellets
and of 7 mm for Hyaff-11 based constructs. Sections were
stained with Safranin-O for sulfated GAG.
Immunohistochemistry
Cryostat sections (3e5 mm thick) were cut from tissues
and pellets stored frozen at 70C. Sections, on Super-
frost slides (BDH, Poole, UK), were ﬁxed for 5 min in ice
cold acetone and then stored at 20C until required for
immunostaining by standard ABC immunoperoxidase
method with a panel of antibodies against collagen type
I (COL-1 Mouse, Sigma, Gillingham, UK), collagen type
II (CIIC1, Developmental Studies Hybridoma Bank, Iowa
City, USA), collagen type III (FH-7A, Sigma, Gillingham,
UK), collagen type IV (CIV22 Dako, Ely, UK) and collagen
type VI (poly, Dako, Ely, UK). Sections immunostained
with anti-type I and type II collagen antibodies were pre-
incubated with 1 mg/mL hyaluronidase (Sigma type 4
hyaluronidase from bovine testes) for 30 min at 37C.
Negative control sections with appropriate immunoglobulin
G (IgG) or non-immune animal serum were run in parallel
with the experimental sections to conﬁrm the speciﬁcity of
any positive staining.
The slides were blindly examined by light microscopy and
the results were scored based on the percentage of positive
tissue as: no matrix positive (); <50% of matrix positive
(þ/); and >50% of matrix positive (þ).
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Immunophenotypic characterization of native and engineered tissues
A: Meniscus B: Model I C: Model II D: Model III
IMC FPC SMC AC IMC FCP SMC AC AC
IN OUT CTR TFP CTR TFP CTR TFP CTR TFP
Col I þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
Col II þ/        þ/ þ/    þ þ
Col III þ þ þ/ þ þ/ þ þ/ þ þ þ þ þ þ þ/ þ
Col IV þ/ þ þ þ þ/ þ þ þ þ/ þ þ þ/ þ þ þ
Col VI þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
The expression of collagen types I, II, III, IV and VI was assessed in the inner avascular (IN) and outer vascular (OUT) regions of native
human meniscus (section A), in pellets generated by IMC, FPC, SMC cells and AC expanded without (control, CTR) or with TFP, after 2 weeks
(section B), in tissue constructs generated by the four different cell sources after 6 weeks of culture into Hyaff-11 (section C), and in tissue
constructs generated by AC cultured for 2 weeks into Hyaff-11 and implanted ectopically for 6 weeks (section D). Scores are based on the
percentage of positive tissue as no matrix positive (); <50% of matrix positive (þ/); and >50% of matrix positive (þ).STATISTICAL ANALYSIS
Values are presented as mean standard deviation. Dif-
ferences between the experimental groups were evaluated
by ManneWhitney U tests and considered statistically
signiﬁcant with P< 0.05.
Results
CHARACTERIZATION OF NATIVE HUMAN MENISCUS
The inner and outer regions of human native meniscus
displayed a uniformly positive immunohistochemical stain-
ing for collagen types I, III and VI. Instead, staining for
collagen type II, the major ﬁbril collagen in articular carti-
lage, was weakly positive only in the inner meniscus region.
Staining for collagen type IV, usually absent from articular
cartilage, was positive, predominantly in a dendritic pattern,
in the outer vascular zone of the meniscus and also, but to
a lower extent, in the inner meniscus (Table I, section A), as
previously described for ovine meniscus41.
CELL PROLIFERATION DURING MONOLAYER EXPANSION
Meniscus, FPC, SMC and AC cultured in control
medium proliferated at similar rates (Fig. 1). However,
probably due to the limited biopsy size (i.e., if lower
than 20 mg), some cultures of meniscus (three primaries),
FPC (four primaries) and SMC (one primary) could not be
expanded.
TFP supplementation during expansion signiﬁcantly
increased the proliferation rate of all four cell types, and
allowed cell expansion even in cases of limited biopsy
size. In the presence of TFP, AC proliferated signiﬁcantly
faster than all other cell sources.
MODEL I: 3D PELLET CULTURES
After 2 weeks of culture, meniscus, SMC and AC
expanded in control medium formed spherical pellets, in
contrast to FPC, which did not generate regular tissue struc-
tures (Fig. 2). Following expansion in control medium, only
AC generated tissues positively stained for GAG. Medium
supplementation with TFP during expansion of all cell sour-
ces resulted in pellets more intensely stained for GAG. A
chondrocytic cell morphology and overtly positive stainingfor GAG were observed in pellets generated by AC and in
restricted regions of pellets generated by FPC and SMC.
Pellets generated by all cell sources, expanded with or
without TFP, contained similar amounts of DNA (data not
shown). Following expansion in control medium, AC gener-
ated pellets with signiﬁcantly higher GAG/DNA fractions
than the other cell sources [Fig. 3(A)]. Medium supplemen-
tation with TFP during expansion induced a signiﬁcant
increase in the GAG/DNA content of pellets generated by
all cell sources (1.4, 4.1, 1.9 and 3.1 fold, respectively, for
meniscus, FPC, SMC and AC). Following TFP expansion,
tissues formed by AC contained the largest fractions of
GAG/DNA.
Following expansion in control medium and differentiation
in pellets, AC expressed the highest mRNA levels of
collagen types I, II and SOX-9 [Fig. 3(BeD)]. Medium
supplementation with TFP during expansion induced a sig-
niﬁcant increase in the mRNA expression of collagen type II
by FPC and SMC (respectively 66- and 472-fold). Following
TFP expansion and differentiation in pellets, AC expressed
mRNA levels of SOX-9 higher than all other cell sources
and of collagen type II higher than meniscus and SMC.
Pellets generated by all cell sources displayed positive
immunohistochemical staining for collagen types I, III, IV
and VI, with generally increased levels of staining following
TFP expansion (Table I, section B). Only AC, expanded
with or without TFP, formed tissues positively stained for
collagen type II, although only in discrete areas.
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Fig. 1. Proliferation index for IMC, FPC, SMC and AC expanded
without control (CTR) or with growth factors (TFP). *¼ signiﬁcantly
different from same cells expanded without TFP.  ¼ signiﬁcantly
different from IMC, FPC and SMC.
52 A. Marsano et al.: Comparison of chondrogenic cellsFig. 2. Representative sections of pellets generated by meniscus (A, B), FPC (C, D), SMC (E, F) and AC (G, H) expanded with (B, D, F, H) or
without (A, C, E, G) the growth factor combination TFP and stained by Safranin-O. Bar¼ 100 mm.MODEL II: CULTURE INTO HYAFF-11 MESHES
All cell sources, expanded in medium supplemented with
TFP and loaded into Hyaff-11 scaffolds, generated tissues
which developed with in vitro culture time. In particular, DNA
fractions of wet weight decreased with time, reaching after 6
weeks similar levels in all constructs (between 0.062% and
0.071% of the wet weight). The GAG content of all con-
structs, expressed as percentage of wet weight, increased
with culture time, and after 6 weeks’ culture was the highest
in tissues generated by AC (1.90 0.09% of the wet weight,
respectively, 2.6-, 2.9- and 3.0-fold higher than in tissues
formed by meniscus, FPC and SMC), approaching the
levels measured in the inner region of native menisci(approximately 2%, calculated based on the study of Auf-
derHeide and Athanasiou 42). Histological staining of tissue
cross-sections indicated that only AC were able after 6
weeks to engineer cartilaginous tissues positively stained
for GAG (Fig. 4).
The pattern of collagen types deposited in cell-Hyaff-11
constructs was similar to that described in cell pellets
(Table I, section C). In particular, tissues generated by AC
were positively stained for all assessed collagen types,
including collagen type II, thus indicating a hybrid ﬁbro-
hyaline cartilaginous nature (Fig. 5). Instead, tissues formed
by meniscus, FPC and SMC were negatively stained for
collagen type II.
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INTO HYAFF-11 MESHES
In order to assess the intrinsic capacity of engineered
cartilage tissues to further develop upon implantation in an
environment supportive, but not inductive, of chondrogene-
sis43, constructs generated by all cell sources, following 2
weeks of pre-culture in vitro44, were implanted in subcutane-
ous pockets in nude mice for 6 weeks. Following in vivo
implantation, the DNA content decreased and reached sim-
ilar levels in all constructs (between 0.030% and 0.047% of
the wet weight). In parallel, the GAG content increased in all
constructs, and reached the highest levels in tissues
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Fig. 3. Fractions of GAG (A) and mRNA expression levels of colla-
gen types I (B), II (C) and Sox9 (D) in pellets generated by IMC,
FPC, SMC and AC, expanded without (control, CTR) or with growth
factors (TFP). *¼ signiﬁcantly different from same cell source ex-
panded without TFP.  ¼ signiﬁcantly different from all the other
cell sources, expanded in the same condition. x ¼ signiﬁcantly dif-
ferent from AC, expanded in the same condition.generated by AC (1.4 0.3% of the wet weight, respec-
tively, 2.6-, 1.9- and 3.5-fold higher than in tissues formed
by meniscus, FPC and SMC). Histologically, tissues formed
by AC were qualitatively similar to those maintained in cul-
ture for a total of 6 weeks (model II), with a mixture of ﬁbro-
blastic and chondrocytic cell phenotypes, large intercellular
spaces positively stained for GAG, and no evidence of vas-
cularization (Fig. 6). Instead, tissues formed by meniscus,
FPC and SMC contained mostly ﬁbroblastic cells and negli-
gible extracellular matrix, with no detectable positive stain
for GAG. As compared to AC-based constructs, the lower
amount of extracellular matrix in meniscus, FPC- and syno-
vial membrane cells-based tissues appeared to be associ-
ated with a more advanced degradation of the esteriﬁed
hyaluronan ﬁbers, which were markedly more swollen, likely
due to increased absorption of water (Fig. 6). Immunohisto-
logical staining of explant cross-sections indicated that
tissues generated by AC were positively stained for
all assessed collagen types, including type II (Table I,
section D). Instead, the amount of extracellular matrix in
meniscus, FPC- and SMC-based tissues was too limited
to allow for reliable immunohistochemical characterization.
Discussion
In this study, with the ultimate goal of identifying a suitable
cell source for engineering autologous meniscus grafts, we
compared the growth and post-expansion chondrogenic ca-
pacity of human meniscus, FPC, SMC and AC using three
different model systems. Our results indicate that (1) AC
reached the highest proliferation rates and (2) only tissues
formed by expanded AC contained molecules typically
found in the inner avascular region of the meniscus (i.e.,
GAG and collagen type II), in the outer vascularized region
of the meniscus (i.e., collagen type IV), and common to both
regions (i.e., collagen types I, III and VI). Instead, under our
speciﬁc experimental setup, tissues formed by meniscus,
FPC, and SMC contained negligible GAG amounts and
no detectable collagen type II.
We initially studied the response of the different cell
sources to a speciﬁc growth factor combination (i.e.,
TFP) supplemented during cell expansion. Medium sup-
plementation with TFP induced a signiﬁcant increase in
the proliferation rate during expansion and in the deposi-
tion of GAG in pellet cultures by all cell sources. In addi-
tion, it induced an upregulation of the mRNA levels of
collagen type II in pellet cultures by FPC and SMC. We
previously reported that in addition to AC29, also chondro-
cytes from ear and nasal septum increased their growth
and post-expansion ability to generate cartilaginous
tissues in response to TFP30. The fact that different chon-
droprogenitor cells and mature chondrocytes from different
cartilage sources similarly responded to the TFP growth
factor combination during expansion suggests that these
different cell types share certain pathways controlling
chondrogenic commitment; in this context, it would be
interesting to assess which common speciﬁc gene sets
are up- or down-regulated in the different cell sources
when exposed to TFP.
Expanded meniscus, FPC and SMC displayed
evidences of differentiation towards the chondrogenic
lineage, as assessed by the detection of type II collagen
and Sox-9 mRNA expression. However, these cells
developed merely ﬁbrocartilaginous tissues, as indicated
by the low amounts of deposited GAG and by the immuno-
histochemical detection of all the investigated collagen
54 A. Marsano et al.: Comparison of chondrogenic cellsFig. 4. Representative Safranin-O stained sections of tissues generated by culture of meniscus (A), FPC (B), SMC (C) and AC (D) into
Hyaff-11 for 6 weeks. Bar¼ 300 mm.types, with the exception of type II collagen. Previous stud-
ies reported the production of type II collagen by
meniscus45, FPC21 and SMC22. The apparent discrepancy
might be explained by the use of different detection
methods and/or by the fact that biopsies taken with differ-
ent methods or from healthy vs injured knees may result in
a different quality of the isolated cells. Indeed, one main
limit of our study is related to the use of likely heteroge-
neous cells, without deﬁnition of typical phenotypes by as-
sessment of surface markers. Our in vivo results are
anyway consistent with the work by De Bari et al.46, re-
porting that no stable cartilage could be formed ectopically
by SMC, and with that by Park et al.47, indicating that
chondrogenesis by synovium-derived cells was not com-
plete, and anyway inferior e with respect to type II colla-
gen and Sox 9 mRNA expression e to that by AC. In
terms of mRNA expression of chondrogenic genes and
GAG deposition, our ﬁndings are also in line with other re-
cent studies, reporting the chondrogenic differentiation of
human SMC in the presence of high concentrations
(500 ng/mL) of bone morphogenetic protein (BMP)-223,48.
However, since these studies did not include assessment
of type II collagen at the protein level, a direct comparison
with our data, potentially addressing the role of BMP-2 in
the system, cannot be established.
In all investigated models, cartilaginous tissues gener-
ated by AC contained all the investigated collagen types
in addition to abundant GAG and thus displayed a mixed
hyaline/ﬁbrous phenotype, consistently with several previ-
ous studies33,49e51. The quality of engineered cartilage
based on AC seeding into Hyaff-11 meshes improved
during time in culture or during the time of subcutaneous
implantation, as assessed by the increased content of
GAG and decreased cellularity. Moreover, cells remained
phenotypically stable and tissues implanted in vivo were
not vascularized, also consistent with a previous report44.
The fact that the GAG content of AC-based constructswas in the range of that measured in the inner region of
the native meniscus would be important to guarantee initial
resistance of the graft upon implantation42,52 and biological
responsiveness to compressive loads53. Moreover, the
expression and deposition by AC of all collagen types
identiﬁed in the native meniscus indicate a compatibility
of their phenotype with meniscus cells. Last but not least,
the relatively higher proliferation rate of AC, especially in
the presence of the growth factor combination TFP, would
allow to generate a sufﬁcient number of cells in a shorter
time.
Although we cannot exclude that different experimental
conditions (e.g., use of different sets of growth factors)
might result in a different trend, data generated using
the described model systems indicate that AC represent
a more appropriate cell source than meniscus, FPC or
SMC for the generation of a meniscus substitute. Recent
studies have already explored the possibility to heal
lesions in the avascular region of the meniscus using
lamb16 or swine AC17, with promising results. Clearly,
tissues engineered by AC only remotely mimic the com-
plex structure of native meniscus; moreover, in our study
we have not investigated the spatial organization of
aggrecan or of collagen ﬁbers, which is known to be
highly speciﬁc in meniscus cartilage54,55. In this regard,
it should be pointed out that differential localization of
speciﬁc matrix molecules in AC-based tissues may be
induced by appropriate physical conditioning in vitro,
e.g., by application of hydrodynamic forces56. Moreover,
it is likely that the composition and mechanical properties
of the graft will correctly develop by adapting to local
mechanical forces upon implantation, as it is described
during the process of embryonic joint development57e59.
In this context, studies are ongoing in a sheep model
to assess the efﬁcacy of autologous AC loaded into
appropriately shaped scaffolds as engineered substitutes
for total meniscectomies.
55Osteoarthritis and Cartilage Vol. 15, No. 1Fig. 5. Representative immunohistochemical stain for collagen types I (A, B), II (C, D), III (E, F), IV (G, H) and VI (I, J) of cartilaginous tissues
generated by culture of AC (A, C, E, G, I) and synovial membrane cells (B, D, F, H, J) into Hyaff-11 for 4 weeks. Immunohistochemical stains
were similar in tissues generated by meniscus, FPC and SMC. Bar¼ 100 mm.
56 A. Marsano et al.: Comparison of chondrogenic cellsFig. 6. Representative Safranin-O stained sections of tissues generated by culture of meniscus (A), FPC (B), SMC (C) and AC (D) into
Hyaff-11 for 2 weeks, followed by 6 weeks of ectopic implantation. Bar¼ 300 mm.Acknowledgements
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